| abstract |
HIV protease inhibitors, obtainable by chemical synthesis, inhibit or block thenbiological activity of the HIV protease enzyme, causing the replication of the HIV virusnto terminate. These compounds, as well as pharmaceutical compositions that containnthese compounds and optionally other anti-viral agents as active ingredients, arensuitable for treating patients or hosts infected with the HIV virus, which is known toncause AIDS. |